Stock A009420 HANALL BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Total Return chart Hanall Biopharma Co., Ltd.

Equities

A009420

KR7009420001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
31,550 KRW -14.50% Intraday chart for Hanall Biopharma Co., Ltd. -11.87% -28.78%
May. 14 Hanall Biopharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 03 HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

Past dividends on Hanall Biopharma Co., Ltd.

2006-12-26 Annual 10 KRW
2004-12-28 Annual 200 KRW
2003-12-28 Annual 250 KRW
2002-12-26 Annual 250 KRW
2001-12-26 Annual 500 KRW
2001-01-01 Annual 400 KRW
2000-01-03 Annual 300 KRW
1999-01-03 Annual 150 KRW
1998-01-02 Annual 225 KRW
1997-01-02 Annual 200 KRW
1996-01-02 Annual 50 KRW
1995-01-02 Annual 50 KRW
1993-01-03 Annual 50 KRW
  1. Stock Market
  2. Equities
  3. A009420 Stock
  4. Charts Hanall Biopharma Co., Ltd.
  5. Total Return chart